<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04512820</url>
  </required_header>
  <id_info>
    <org_study_id>005-20-AAA</org_study_id>
    <nct_id>NCT04512820</nct_id>
  </id_info>
  <brief_title>Treatment of Missed Miscarriage With TRUCLEAR Tissue Removal System, a Feasiblity Study</brief_title>
  <official_title>Embryoscopic Evacuation of Early Missed Abortion Using the TRUCLEAR Hysteroscopic Morcellator System a Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assuta Ashdod Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assuta Ashdod Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      the Aim of this study is to prospectively study the feasibility of evacuation of products of&#xD;
      conception (POC) in missed miscarriages up to 10 weeks using the TRUCLEAR tissue removal&#xD;
      system in order to achieve targeted treatment under direct vision of the POC and thus&#xD;
      potentially reducing the risk of complications and intrauterine adhesions&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Embryoscopy and fetoscopy had been used increasingly in the treatment of missed abortions in&#xD;
      the last two decades. This is done simply by transcervical hysteroscopy during pregnancy. The&#xD;
      fact that we can directly view the embryo in the gestational sack allows us to document and&#xD;
      describe the fetal morphology and to note different anatomical malformations. Phillips et al&#xD;
      (1) described in 2001 the use of embryoscpy prior to evacuation of the uterus in early missed&#xD;
      abortions in order to diagnose anatomical malformations and to allow sampling of the fetal&#xD;
      tissues for genetic testing. This group had also demonstrated that patients with repeated&#xD;
      pregnancy loss are more likely to have morphologically normal embryos and less aneuploidy in&#xD;
      cytogenetic analysis (2). The use of fetal tissue obtained in embryoscopy allows for a more&#xD;
      accurate genetic testing and diagnosis and reduces the amount of maternal cells in the&#xD;
      specimen (3).&#xD;
&#xD;
      Hysteroscopic morcellation had been used for intrauterine tissue extraction for over 20&#xD;
      years. Hysteroscopic morcellators have been shown to allow for rapid and complete resection&#xD;
      of polyps, fibroids, uterine septa and retained products of conception (4). These instruments&#xD;
      use a rotating blade and a suction system that allows for removal for the specimen under&#xD;
      direct hysteroscopic visualization. When compared with standard resectoscopic technique, the&#xD;
      use of hysteroscopic morcellators probably saves time and allows for more complete removal of&#xD;
      the specimen (4).&#xD;
&#xD;
      Use of the hysteroscopic morcellator for resection of the fetal tissue in early missed&#xD;
      abortions might prove beneficial over the standard blind Dilatation and curettage currently&#xD;
      used to treat this condition. This technique might allow selective targeting of the fetal&#xD;
      tissue thus decreasing the damage caused by trauma to the entire uterine cavity. In a recent&#xD;
      systematic review (5) the rate of intrauterine adhesions following D&amp;C for missed abortions&#xD;
      ranged between 16 to 21 percent. This technique was assessed in one case for a woman with&#xD;
      previous Ashreman's syndrome and was found to be feasible although the authors state that&#xD;
      visibility was poor while resecting the implantation site due to high vascularization (6).&#xD;
&#xD;
      The primary aim of the current study is to assess the feasibility of embryolysis - resection&#xD;
      of an early missed abortion with the Truclear 8 mm hysteroscopic morcellator.&#xD;
&#xD;
      Secondary aims include the rate of complications, incomplete removal and intrauterine&#xD;
      adhesions.&#xD;
&#xD;
      In this pilot feasibility study, we hypothesize that the 8mm Truclear Morcellator system will&#xD;
      be able to achieve full evacuation of the uterine cavity. Performed under direct&#xD;
      visualization and focused only on the implantation site, thus reducing the potential for&#xD;
      further intrauterine adhesions.&#xD;
&#xD;
        1. Philipp T, Kalousek DK. Transcervical embryoscopy in missed abortion. J Assist Reprod&#xD;
           Genet. 2001 May;18(5):285-90.&#xD;
&#xD;
        2. Feichtinger M, Wallner E, Hartmann B, Reiner A, Philipp T. Transcervical embryoscopic&#xD;
           and cytogenetic findings reveal distinctive differences in primary and secondary&#xD;
           recurrent pregnancy loss. Fertil Steril. 2017 Jan;107(1):144-149. doi:&#xD;
           10.1016/j.fertnstert.2016.09.037. Epub 2016 Oct 12.&#xD;
&#xD;
        3. Campos-Galindo I1, García-Herrero S, Martínez-Conejero JA, Ferro J, Simón C, Rubio C.&#xD;
           Molecular analysis of products of conception obtained by hysteroembryoscopy from&#xD;
           infertile couples. J Assist Reprod Genet. 2015 May;32(5):839-48. doi:&#xD;
           10.1007/s10815-015-0460-z. Epub 2015 Mar 17.&#xD;
&#xD;
        4. Shazly SA, Laughlin-Tommaso SK, Breitkopf DM, Hopkins MR, Burnett TL, Green IC, Farrell&#xD;
           AM, Murad MH, Famuyide AO. Hysteroscopic Morcellation Versus Resection for the Treatment&#xD;
           of Uterine Cavitary Lesions: A Systematic Review and Meta-analysis. Minim Invasive&#xD;
           Gynecol. 2016 Sep-Oct;23(6):867-77. doi: 10.1016/j.jmig.2016.04.013. Epub 2016 May 7.&#xD;
&#xD;
        5. Hooker A, Fraenk D, Brölmann H, Huirne J. Prevalence of intrauterine adhesions after&#xD;
           termination of pregnancy: a systematic review. Eur J Contracept Reprod Health Care. 2016&#xD;
           Aug;21(4):329-35. doi: 10.1080/13625187.2016.1199795.&#xD;
&#xD;
        6. Harpham M, Abbott J. Use of a hysteroscopic morcellator to resect miscarriage in a woman&#xD;
           with recurrent Asherman's syndrome. J Minim Invasive Gynecol. 2014&#xD;
           Nov-Dec;21(6):1118-20. doi: 10.1016/j.jmig.2014.05.006. Epub 2014 May 24.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 5, 2020</start_date>
  <completion_date type="Anticipated">January 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>completion of the procedure</measure>
    <time_frame>immediate - during the procedure</time_frame>
    <description>completion of the procedure undervision without need to resort to suction &amp; curettage</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>complications</measure>
    <time_frame>within two weeks from the procedure</time_frame>
    <description>uterine perforation, infection, bleeding and pain that requires admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incomplete removal</measure>
    <time_frame>within 8 weeks</time_frame>
    <description>presence of retained products of conception on ultrasound scan or hysteroscopy</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Miscarriage</condition>
  <arm_group>
    <arm_group_label>TRUCLEAR TREATMENT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients up to 10 weeks of gestation with missed miscarriage undergoing evacuation of products of conception using the TRUCLEAR tissue removal system under direct hysteroscopic visualization</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TRUCLEAR tissue removal system</intervention_name>
    <description>evacuation of POC using the TRUCLEAR tissue removal system</description>
    <arm_group_label>TRUCLEAR TREATMENT</arm_group_label>
    <other_name>non</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with missed miscarriage up to 10 weeks from the last menstrual period&#xD;
&#xD;
          -  Patients are able to provide written consent&#xD;
&#xD;
          -  Patients with no underlying medical conditions&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to consent due to cognitive or language barrier&#xD;
&#xD;
          -  Any underlying medical condition requiring medical treatment&#xD;
&#xD;
          -  Documented failed hysteroscopy prior to the current referral&#xD;
&#xD;
          -  Inability to consent due to cognitive or language barrier&#xD;
&#xD;
          -  Uterine malformations or fibroids&#xD;
&#xD;
          -  Previous cesarean section&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Oshri Barel, MD</last_name>
    <phone>+927559382117</phone>
    <email>Oshrib@assuta.co.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assuta Ashdod University Hospital</name>
      <address>
        <city>Ashdod</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oshri Barel, MD</last_name>
      <phone>+972559382117</phone>
      <email>oshrib@assuta.co.il</email>
    </contact>
    <investigator>
      <last_name>Oshri Barel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Philipp T, Kalousek DK. Transcervical embryoscopy in missed abortion. J Assist Reprod Genet. 2001 May;18(5):285-90.</citation>
    <PMID>11464580</PMID>
  </reference>
  <reference>
    <citation>Feichtinger M, Wallner E, Hartmann B, Reiner A, Philipp T. Transcervical embryoscopic and cytogenetic findings reveal distinctive differences in primary and secondary recurrent pregnancy loss. Fertil Steril. 2017 Jan;107(1):144-149. doi: 10.1016/j.fertnstert.2016.09.037. Epub 2016 Oct 12.</citation>
    <PMID>27743696</PMID>
  </reference>
  <reference>
    <citation>Campos-Galindo I, García-Herrero S, Martínez-Conejero JA, Ferro J, Simón C, Rubio C. Molecular analysis of products of conception obtained by hysteroembryoscopy from infertile couples. J Assist Reprod Genet. 2015 May;32(5):839-48. doi: 10.1007/s10815-015-0460-z. Epub 2015 Mar 17.</citation>
    <PMID>25779005</PMID>
  </reference>
  <reference>
    <citation>Shazly SA, Laughlin-Tommaso SK, Breitkopf DM, Hopkins MR, Burnett TL, Green IC, Farrell AM, Murad MH, Famuyide AO. Hysteroscopic Morcellation Versus Resection for the Treatment of Uterine Cavitary Lesions: A Systematic Review and Meta-analysis. J Minim Invasive Gynecol. 2016 Sep-Oct;23(6):867-77. doi: 10.1016/j.jmig.2016.04.013. Epub 2016 May 7. Review.</citation>
    <PMID>27164165</PMID>
  </reference>
  <reference>
    <citation>Hooker A, Fraenk D, Brölmann H, Huirne J. Prevalence of intrauterine adhesions after termination of pregnancy: a systematic review. Eur J Contracept Reprod Health Care. 2016 Aug;21(4):329-35. doi: 10.1080/13625187.2016.1199795. Review.</citation>
    <PMID>27436757</PMID>
  </reference>
  <reference>
    <citation>Harpham M, Abbott J. Use of a hysteroscopic morcellator to resect miscarriage in a woman with recurrent Asherman's syndrome. J Minim Invasive Gynecol. 2014 Nov-Dec;21(6):1118-20. doi: 10.1016/j.jmig.2014.05.006. Epub 2014 May 24.</citation>
    <PMID>24865632</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>August 11, 2020</study_first_submitted>
  <study_first_submitted_qc>August 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2020</study_first_posted>
  <last_update_submitted>August 11, 2020</last_update_submitted>
  <last_update_submitted_qc>August 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abortion, Spontaneous</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>only unidentified data will be shared</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

